71 filings
Page 4 of 4
8-K
ijiyf tmquz
8 Nov 18
Results of Operations and Financial Condition
4:35pm
8-K
3nlus7ozgc5eskuk
1 Nov 18
Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases
6:08am
8-K
8c0yo7mqf6zwwg
9 Aug 18
Denali Therapeutics Reports Second Quarter 2018 Financial Results
12:00am
8-K
rpzo3 vas
1 Aug 18
Denali Therapeutics Announces Positive Clinical Results from LRRK2 Inhibitor Program for Parkinson’s Disease
4:38pm
8-K
ac0r8eb1rt6q1sv3jr1
15 Jun 18
Submission of Matters to a Vote of Security Holders
4:22pm
8-K
4ocopk8btg0gv9j
30 May 18
Denali Therapeutics Announces Early Exercise of Its Option to Acquire F-star Gamma
4:36pm
8-K
hqnulr
11 May 18
Denali Therapeutics Reports First Quarter 2018 Financial Results
8:01am
8-K
mxsrns7oc3zjxzbf6yq
7 May 18
Entry into a Material Definitive Agreement
4:31pm
8-K
zvruc
19 Mar 18
Results of Operations and Financial Condition
12:00am
8-K
2hmmw
5 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
e5uutr5ldyl5y66c3466
12 Dec 17
Denali Therapeutics Announces Closing of Initial Public Offering, Including Full
12:00am